Crinetics Pharmaceuticals, Inc.（CRNX）内部人交易：高管与董事近期交易
过去 18 个月，共有 14 位内部人为 Crinetics Pharmaceuticals, Inc.（CRNX）报告了 112 笔 Form 4 交易（最近一笔 2026-09-01）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-01 | WIERENGA WENDELL | 董事 | 卖出 | 116,146 | $9.9M |
| 2026-09-01 | Deardorf Caren | 董事 | 卖出 | 5,925 | $503,625 |
| 2026-09-01 | Fust Matthew K | 董事 | 卖出 | 22,836 | $1.9M |
| 2026-09-01 | Vivaldi Coelho Rogerio | 董事 | 卖出 | 13,300 | $1.1M |
| 2026-09-01 | Schilke Tobin | Chief Financial & Infra. Ofcr. | 卖出 | 7,956 | $676,260 |
| 2026-09-01 | Okey Stephanie | 董事 | 卖出 | 6,400 | $544,000 |
| 2026-09-01 | Struthers Richard Scott | President & CEO | 卖出 | 248,043 | $21.1M |
| 2026-09-01 | Bedrosian Camille L | 董事 | 卖出 | 16,300 | $1.4M |
| 2026-09-01 | Deardorf Caren | 董事 | 卖出 | 16,300 | $1.4M |
| 2026-09-01 | Betz Stephen F. | Chief Scientific Officer | 卖出 | 58,286 | $5.0M |
| 2026-09-01 | Kalofonos Isabel | Chief Commercial Officer | 卖出 | 1,669 | $141,865 |
| 2026-09-01 | WIERENGA WENDELL | 董事 | 卖出 | 5,925 | $503,625 |
| 2026-09-01 | Bedrosian Camille L | 董事 | 卖出 | 5,925 | $503,625 |
| 2026-09-01 | Fust Matthew K | 董事 | 卖出 | 5,925 | $503,625 |
| 2026-09-01 | Vivaldi Coelho Rogerio | 董事 | 卖出 | 5,925 | $503,625 |
| 2026-09-01 | Schilke Tobin | Chief Financial & Infra. Ofcr. | 卖出 | 71,471 | $6.1M |
| 2026-09-01 | Okey Stephanie | 董事 | 卖出 | 5,925 | $503,625 |
| 2026-09-01 | Struthers Richard Scott | President & CEO | 卖出 | 1,000 | $85,000 |
| 2026-09-01 | Nichols Weston | 董事 | 卖出 | 5,925 | $503,625 |
| 2026-09-01 | Struthers Richard Scott | President & CEO | 卖出 | 110,000 | $9.3M |
| 2026-09-01 | Betz Stephen F. | Chief Scientific Officer | 卖出 | 79,650 | $6.8M |
| 2026-09-01 | Kalofonos Isabel | Chief Commercial Officer | 卖出 | 34,000 | $2.9M |
| 2026-09-01 | Struthers Richard Scott | President & CEO | 卖出 | 136,805 | $11.6M |
| 2026-09-01 | Struthers Richard Scott | President & CEO | 卖出 | 106,000 | $9.0M |
| 2026-09-01 | Nichols Weston | 董事 | 卖出 | 16,300 | $1.4M |
来源：SEC Form 4 申报文件 · 截至 2026-09-01